Literature DB >> 12101258

Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes.

Gail A Bishop1, Bruce S Hostager, Kevin D Brown.   

Abstract

A key component of signaling by members of the tumor necrosis factor receptor (TNF-R) family is interaction with the cytoplasmic adapter proteins known as TRAFs. Several proteins encoded by microbes also interact with TRAFs. A notable example is the CD40 receptor, expressed on antigen presenting cells and providing key activation signals in T cell-dependent B cell activation. CD40 signals to B cells are mimicked by a constitutively active viral protein produced by the Epstein-Barr virus. For each of these receptors, multiple mechanisms of TRAF regulation contribute to signal transduction and the ultimate effect on the B cell. Recent findings concerning these regulatory mechanisms are summarized in this overview.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101258

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

1.  Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.

Authors:  John P Graham; Carissa R Moore; Gail A Bishop
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

2.  CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.

Authors:  Jose-Andres C Portillo; Luis Muniz Feliciano; Genevieve Okenka; Frederick Heinzel; M Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

3.  Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).

Authors:  Kelly M Arcipowski; Laura L Stunz; John P Graham; Zachary J Kraus; Tony J Vanden Bush; Gail A Bishop
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

4.  Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling.

Authors:  Jose-Andres C Portillo; Isaac Schwartz; Simona Zarini; Reena Bapputty; Timothy S Kern; Rose A Gubitosi-Klug; Robert C Murphy; M Cecilia Subauste; Carlos S Subauste
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-04       Impact factor: 4.799

Review 5.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

6.  Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Isaac Schwartz; Maria Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

7.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

8.  Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.

Authors:  Dun-Fa Peng; Tian-Ling Hu; Mohammed Soutto; Abbes Belkhiri; Wael El-Rifai
Journal:  Carcinogenesis       Date:  2014-04-01       Impact factor: 4.944

Review 9.  The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.

Authors:  Michael P Cancro; David P D'Cruz; Munther A Khamashta
Journal:  J Clin Invest       Date:  2009-05-01       Impact factor: 14.808

10.  Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function.

Authors:  Abdur Rub; Ranadhir Dey; Meenakshi Jadhav; Rohan Kamat; Santhosh Chakkaramakkil; Subrata Majumdar; Robin Mukhopadhyaya; Bhaskar Saha
Journal:  Nat Immunol       Date:  2009-02-08       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.